[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fZuEqzDXVduYBo5C-7qlYmBQSrAqaG-3tom1xolBEkoc":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":33,"phaseBuckets":34,"rows":41},"Vedic Lifesciences Pvt. Ltd.",[4],72,false,7,1,7733,0,66,[14,17,20,22,25,27,29,31],{"name":15,"count":16},"Knee Osteoarthritis",4,{"name":18,"count":19},"Gut Health",3,{"name":21,"count":19},"Joint Pain",{"name":23,"count":24},"Osteoarthritis",2,{"name":26,"count":24},"Pre Diabetes",{"name":28,"count":24},"Fatigue",{"name":30,"count":24},"Upper Respiratory Tract Infection",{"name":32,"count":24},"Overweight and Obesity",[],[35,36,37,38,39,40],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[42,68,96,114,132,150,174,199,224,249],{"intervention":43,"totalTrials":9,"cells":44},"Lactobacillus Species",{"EARLY_PHASE1":45,"PHASE1":47,"PHASE2":49,"PHASE3":51,"PHASE4":53,"NA":66},{"trials":46,"activeCount":11},[],{"trials":48,"activeCount":11},[],{"trials":50,"activeCount":11},[],{"trials":52,"activeCount":11},[],{"trials":54,"activeCount":11},[55],{"nctId":56,"briefTitle":57,"status":58,"phases":59,"primaryCompletion":60,"completion":60,"start":61,"enrollment":62,"conditions":63,"interventions":65},"NCT05060029","A Pilot Study to Evaluate the Efficacy and Safety of Lactobacillus Species Suppositories on Vaginal Health and pH","UNKNOWN",[39],"2022-08-12","2022-01-03",75,[64],"Bacterial Vaginosis",[43],{"trials":67,"activeCount":11},[],{"intervention":69,"totalTrials":9,"cells":70},"A. Paniculata",{"EARLY_PHASE1":71,"PHASE1":73,"PHASE2":75,"PHASE3":77,"PHASE4":92,"NA":94},{"trials":72,"activeCount":11},[],{"trials":74,"activeCount":11},[],{"trials":76,"activeCount":11},[],{"trials":78,"activeCount":11},[79],{"nctId":80,"briefTitle":81,"status":82,"phases":83,"primaryCompletion":84,"completion":84,"start":85,"enrollment":86,"conditions":87,"interventions":88},"NCT04955327","To Compare the Efficacy and Tolerability of A. Paniculata\u002FA. Chilensis in Individuals With URTI","COMPLETED",[38],"2022-02-25","2021-03-20",225,[30],[69,89,90,91],"A. Chilensis","A. Paniculata and A. Chilensis","Microcrystalline cellulose",{"trials":93,"activeCount":11},[],{"trials":95,"activeCount":11},[],{"intervention":89,"totalTrials":9,"cells":97},{"EARLY_PHASE1":98,"PHASE1":100,"PHASE2":102,"PHASE3":104,"PHASE4":110,"NA":112},{"trials":99,"activeCount":11},[],{"trials":101,"activeCount":11},[],{"trials":103,"activeCount":11},[],{"trials":105,"activeCount":11},[106],{"nctId":80,"briefTitle":81,"status":82,"phases":107,"primaryCompletion":84,"completion":84,"start":85,"enrollment":86,"conditions":108,"interventions":109},[38],[30],[69,89,90,91],{"trials":111,"activeCount":11},[],{"trials":113,"activeCount":11},[],{"intervention":90,"totalTrials":9,"cells":115},{"EARLY_PHASE1":116,"PHASE1":118,"PHASE2":120,"PHASE3":122,"PHASE4":128,"NA":130},{"trials":117,"activeCount":11},[],{"trials":119,"activeCount":11},[],{"trials":121,"activeCount":11},[],{"trials":123,"activeCount":11},[124],{"nctId":80,"briefTitle":81,"status":82,"phases":125,"primaryCompletion":84,"completion":84,"start":85,"enrollment":86,"conditions":126,"interventions":127},[38],[30],[69,89,90,91],{"trials":129,"activeCount":11},[],{"trials":131,"activeCount":11},[],{"intervention":91,"totalTrials":9,"cells":133},{"EARLY_PHASE1":134,"PHASE1":136,"PHASE2":138,"PHASE3":140,"PHASE4":146,"NA":148},{"trials":135,"activeCount":11},[],{"trials":137,"activeCount":11},[],{"trials":139,"activeCount":11},[],{"trials":141,"activeCount":11},[142],{"nctId":80,"briefTitle":81,"status":82,"phases":143,"primaryCompletion":84,"completion":84,"start":85,"enrollment":86,"conditions":144,"interventions":145},[38],[30],[69,89,90,91],{"trials":147,"activeCount":11},[],{"trials":149,"activeCount":11},[],{"intervention":151,"totalTrials":9,"cells":152},"Ibuprofen",{"EARLY_PHASE1":153,"PHASE1":155,"PHASE2":157,"PHASE3":159,"PHASE4":161,"NA":163},{"trials":154,"activeCount":11},[],{"trials":156,"activeCount":11},[],{"trials":158,"activeCount":11},[],{"trials":160,"activeCount":11},[],{"trials":162,"activeCount":11},[],{"trials":164,"activeCount":11},[165],{"nctId":166,"briefTitle":167,"status":82,"phases":168,"primaryCompletion":169,"completion":169,"start":170,"enrollment":6,"conditions":171,"interventions":173},"NCT02417506","Study to Assess the Effect of E-OA-07 on Acute Pain Response in Subjects Suffering From Knee OA",[40],"2015-02","2014-08",[172],"Osteoarthritis of Knee",[151],{"intervention":175,"totalTrials":9,"cells":176},"150 mg 5-ALAPhosphate + SFC",{"EARLY_PHASE1":177,"PHASE1":179,"PHASE2":181,"PHASE3":183,"PHASE4":185,"NA":187},{"trials":178,"activeCount":11},[],{"trials":180,"activeCount":11},[],{"trials":182,"activeCount":11},[],{"trials":184,"activeCount":11},[],{"trials":186,"activeCount":11},[],{"trials":188,"activeCount":11},[189],{"nctId":190,"briefTitle":191,"status":82,"phases":192,"primaryCompletion":193,"completion":193,"start":194,"enrollment":195,"conditions":196,"interventions":198},"NCT05234346","ALACOVID Study for Vaccinated Subjects",[40],"2022-06-18","2022-03-15",200,[197],"COVID-19 Respiratory Infection",[175],{"intervention":200,"totalTrials":9,"cells":201},"Amino Acid",{"EARLY_PHASE1":202,"PHASE1":204,"PHASE2":206,"PHASE3":208,"PHASE4":210,"NA":212},{"trials":203,"activeCount":11},[],{"trials":205,"activeCount":11},[],{"trials":207,"activeCount":11},[],{"trials":209,"activeCount":11},[],{"trials":211,"activeCount":11},[],{"trials":213,"activeCount":11},[214],{"nctId":215,"briefTitle":216,"status":82,"phases":217,"primaryCompletion":218,"completion":218,"start":219,"enrollment":220,"conditions":221,"interventions":223},"NCT04785170","Clinical Study to Evaluate Safety and Efficacy of Amino Acid in Healthy Individuals",[40],"2021-03-26","2021-02-02",13,[222],"Safety and Efficacy",[200],{"intervention":225,"totalTrials":9,"cells":226},"Collagen type II",{"EARLY_PHASE1":227,"PHASE1":229,"PHASE2":231,"PHASE3":233,"PHASE4":235,"NA":237},{"trials":228,"activeCount":11},[],{"trials":230,"activeCount":11},[],{"trials":232,"activeCount":11},[],{"trials":234,"activeCount":11},[],{"trials":236,"activeCount":11},[],{"trials":238,"activeCount":11},[239],{"nctId":240,"briefTitle":241,"status":58,"phases":242,"primaryCompletion":243,"completion":243,"start":244,"enrollment":245,"conditions":246,"interventions":247},"NCT05212259","Clinical Study to Evaluate the Effect of Different Doses of UC-II® Supplementation on the Range of Motion & Joint Discomfort in Healthy Subjects",[40],"2023-09-15","2022-10-10",375,[21],[225,225,225,248],"Glucosamine Hydrochloride with Chondroitin Sulphate",{"intervention":248,"totalTrials":9,"cells":250},{"EARLY_PHASE1":251,"PHASE1":253,"PHASE2":255,"PHASE3":257,"PHASE4":259,"NA":261},{"trials":252,"activeCount":11},[],{"trials":254,"activeCount":11},[],{"trials":256,"activeCount":11},[],{"trials":258,"activeCount":11},[],{"trials":260,"activeCount":11},[],{"trials":262,"activeCount":11},[263],{"nctId":240,"briefTitle":241,"status":58,"phases":264,"primaryCompletion":243,"completion":243,"start":244,"enrollment":245,"conditions":265,"interventions":266},[40],[21],[225,225,225,248]]